Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy

BJU International

Volumn 97, Issue 5, 2006, Pages 985-991

  Kroepfl, Darko ^a   Loewen, Heinrich ^a   Roggenbuck, Ulla ^b   Musch, Michael ^a   Klevecka, Virgilius ^a  

^a KLINIKEN ESSEN MITTE   (Germany)

^b UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

Disease progression; Hormonal treatment; Positive lymph nodes; Radical prostatectomy

Indexed keywords

ANTIANDROGEN; BICALUTAMIDE; FLUTAMIDE; HORMONE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BONE METASTASIS; CALCULATION; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE COURSE; DRUG MECHANISM; FOLLOW UP; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL TEST; MEDICAL DOCUMENTATION; MEDICAL RECORD; PATHOGENESIS; PELVIS LYMPHADENECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CARCINOMA; PROSTATECTOMY; QUESTIONNAIRE; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADULT; AGED; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORCHIECTOMY; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 33645728376     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06129.x     Document Type: Article

References (27)

1. Burkhard FC Bader P Schneider E Markwalder R Studer UE Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection Eur Urol 2002 42 84 92
2. Heidenreich A Varga Z Von Knobloch R Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis J Urol 2002 167 1681 6
3. McDowell GC Johnson JW Tenney DM Johnson DE Pelvic lymphadenectomy for staging clinically localized prostate cancer. Indications, complications, and results in 217 cases Urology 1990 35 476 82
4. Naya Y Babaian RJ The predictors of pelvic lymph node metastasis at radical retropubic prostatectomy J Urol 2003 170 2306 10
5. Conrad S Graefen M Pichlmeier U Henke RP Hammerer PG Huland H Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma J Urol 1998 159 2023 9
6. deKernion JB Neuwirth H Stein A et al. Prognosis of patients with stage D1 prostate carcinoma following radical prostatectomy with and without early endocrine therapy J Urol 1990 144 700 3
7. Frohmuller HG Theiss M Manseck A Wirth MP Survival and quality of life of patients with stage D1 (T1-3 pN1-2 M0) prostate cancer. Radical prostatectomy plus androgen deprivation versus androgen deprivation alone Eur Urol 1995 27 202 6
8. Grimm MO Kamphausen S Hugenschmidt H Stephan-Odenthal M Ackermann R Vogeli TA Clinical outcome of patients with lymph node positive prostate cancer after radical prostatectomy versus androgen deprivation Eur Urol 2002 41 628 34
9. Schroder FH Kurth KH Fossa SD et al. Early versus delayed endocrine treatment of pN1-3 M0 prostate cancer without local treatment of the primary tumor: results of European Organisation for the Research and Treatment of Cancer 30846 - a phase III study J Urol 2004 172 923 7
10. Zincke H Utz DC Myers RP Farrow GM Patterson DE Furlow WL Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma of prostate with regional lymph node involvement Urology 1982 19 238 47
11. Cadeddu JA Partin AW Epstein JI Walsh PC Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy Urology 1997 50 251 5
12. Bader P Burkhard FC Markwalder R Studer UE Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 2003 169 849 54
13. Schmid HP Mihatsch MJ Hering F Rutishauser G Impact of minimal lymph node metastasis on long-term prognosis after radical prostatectomy Eur Urol 1997 31 11 6
14. Seay TM Blute MC Zincke H Radical prostatectomy and early adjuvant hormonal therapy for pTxN+ adenocarcinoma of the prostate Urology 1997 50 833 7
15. Sgrignoli AR Walsh PC Steinberg GD Steiner MS Epstein JI Prognostic factors in men with stage D1 prostate cancer identification of patients less likely to have prolonged survival after radical prostatectomy J Urol 1994 152 1077 81
16. Daneshmand S Quek ML Stein JP et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results J Urol 2004 172 2252 5
17. Messing EM Manola J Sarosdy M Wilding G Crawford ED Trump D Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer N Engl J Med 1999 341 1781 8
18. Bolla M Collette L Blank L et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial Lancet 2002 360 103 6
19. Iversen P Tyrrell CJ Kaisary AV et al. Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years Urology 1998 51 389 96
20. Iversen P Tyrrell CJ Kaisary AV et al. Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup J Urol 2000 164 1579 82
21. Kramolowsky EV The value of testosterone deprivation in stage D1 carcinoma of the prostate J Urol 1988 139 1242 4
22. Cheng L Zincke H Blute ML Bergstralh EJ Scherer B Bostwick DG Risk of prostate carcinoma death in patients with lymph node metastasis Cancer 2001 91 66 73
23. Ghavamian R Bergstralh EJ Blute ML Slezak J Zincke H Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison J Urol 1999 161 1223 8
24. Messing EM Manola J Sarosdy M Wilding G Crawford ED Trump D Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer: results at 10 years of EST 3886 J Urol 2003 164 369 Abstract
25. Zwergel U Lehmann J Wullich B et al. Lymph node positive prostate cancer: long-term survival data after radical prostatectomy J Urol 2004 171 1128 31
26. Steinberg DM Sauvageot J Piantadosi S Epstein JI Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings Am J Surg Pathol 1997 21 566 76
27. Bostwick DG Qian J Schlesinger C Contemporary pathology of prostate cancer Urol Clin North Am 2003 30 181 207